appear to be treating this as a GGB takeover offer of APHA in their number crunching and as an RTO when explaining the outcome and motives behind the outcome. They should have been using the M&A 101 metrics from the perspective of a takeover offer by APHA or GGB if their theory was indeed to prove an RTO attempt.
We foresaw M&A activity as far back as my first article appearing in the US edition a few years back because the consolidation curve cannot be avoided or side stepped. In December, we alerted you to the fact that Emblem appeared to be ideal for investing in and we know what happened within days of our published content. A more recent M&A involves Westleaf’s M&A of a private company (Canndara Canada Inc).
I wish I could say we predicted this supply shortage facing Canada when others did not (one former top industry personality even went as far as predicting a gluttony) but the truth is one cannot take credit for predicting that the sun will set each day in the West. What we can take credit for predicting is that the shortage could last years whereas some assumed that an equilibrium would be realized within months of the end of prohibition. This recent article
(BNN Bloomberg) validates our prediction as evidenced by its model projecting shortages outward as far as five years. As an investor this is a strong indicator that substantial growth may exist for some time and there will be a rise of opportunities in the ancillary market. It is not by coincidence that 3 Sixty Services Corp (CSE:SAFE) is our feature company this month and I hope you take a few months to read our exclusive interview and Q&A with their CEO Thomas Gerstenecker.
Always remember that despite what I feel is our industry leading strategies and content with proven superior returns and that our models and content are sometimes copied by others - all our content is to raise awareness and education and is not considered investment, financial, or health advice.
91